Chitotriosidase: A New Inflammatory Marker in Diabetic Complications.
Chitotriosidase (CHIT1) belongs to chitinase family. So far this enzyme has been the best investigated human chitinase regarding its biological activity and association with various disorders. In a healthy population, CHIT1 activity is very low and originates in the circulating polymorphonuclear cells. Conversely, during the development of acute/chronic inflammatory disorders, the enzymatic activity of CHIT1 increases significantly. Recently, CHIT1 has also been involved in the pathogenesis of diabetes mellitus (DM). Mounting evidence from experimental studies revealing the increase of CHIT1 levels in pathological conditions, such as atherosclerosis, coronary artery disease, acute ischemic stroke, cerebrovascular dementia, nonalcoholic fatty liver disease, and osteolytic processes suggest its critical role in the evolutions and complications of DM. This review is addressed to provide mechanistic insights by highlighting the relationship between CHIT1 and diabetes, and their contribution in the exacerbation of this disease.
Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
Michelino
M
Di Rosa
Lucia
L
Malaguarnera
D015415:Biomarkers / Q000378:metabolism; D048909:Diabetes Complications / Q000378:metabolism* / Q000473:pathology; D003920:Diabetes Mellitus / Q000378:metabolism* / Q000473:pathology; D006596:Hexosaminidases / Q000378:metabolism*; D006801:Humans
D015415:Biomarkers; D006596:Hexosaminidases; C086400:chitotriosidase